Comprehensive assessment of inflammatory, epigenetic, and cardioimaging biomarkers in the progressive course of coronary heart disease
Abstract
Aim. In this study, the prognostic significance of a multibiomarker model, including epigenetic markers (miR-155), inflammatory cytokines (TNF-α, IL-1β) and noninvasive cardiovisualizing patterns, was evaluated for assessing the risk of progressive coronary heart disease (CHD).
Materials and methods. A comprehensive assessment of correlations between the parameters of coronary atherosclerosis according to contrast MSCT angiography (coronary calcium index, degree of stenosis, remodeling index, index of involvement-SIS, density, volume and mass of plaques) and biomarker levels was carried out in 152 patients with stable and unstable forms of coronary artery disease. miR-155 expression was determined by real-time polymerase chain reaction on a Rotor–Gene Q device, and concentrations of proinflammatory cytokines were determined by enzyme immunoassay.
Results. A comprehensive assessment of correlations between the parameters of coronary atherosclerosis according to contrast MSCT angiography (coronary calcium index, degree of stenosis, remodeling index, index of involvement-SIS, density, volume and mass of plaques) and biomarker levels was carried out in 152 patients with stable and unstable forms of coronary artery disease. miR-155 expression was determined by real-time polymerase chain reaction on a Rotor–Gene Q device, and concentrations of proinflammatory cytokines were determined by enzyme immunoassay.
Conclusion. The data obtained confirm that this multibiomarker panel is a promising tool for early detection, risk assessment, and the development of individual management strategies for patients with coronary heart disease. Combined assessment of epigenetic, inflammatory, and cardiovisual biomarkers can improve risk stratification and aid in clinical decision-making.
About the Authors
List of references
R. McPherson and A. Tybjaerg-Hansen, “Genetics of Coronary Artery Disease,” Circulation Research, vol. 118, no. 4, pp. 564–578, 2016.
S. A. Choteau, L. F. Cuesta Torres, J. Y. Barraclough, A. M. Elder, G. J. Mart´ınez, W. Y. Chen Fan, and S. Shrestha, "Transcoronary gradients of HDL-associated MicroRNAs in unstable coronary artery disease,"International Journal of Cardiology, vol. 253, pp. 138–144, 2018.
S. De Rosa, S. Fichtlscherer, R. Lehmann, B. Assmus, S. Dimmeler, and A. M. Zeiher, "Transcoronary concentration gradients of circulating microRNAs,"Circulation, vol. 124, pp. 1936–1944, 2011.
R. R. Packard and P. Libby, "Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction,"Clinical Chemistry, vol. 54, pp. 24–38, 2008.
S. Taurone, M. T. Santarelli, E. De Santis, C. Di Gioia, E. Pompili, F. Pellegrino, P. Familiari, V. Papa, C. Zanza, L. Coppola, G. Familiari, and M. Artico, "Porcine coronary arteries: immunohistochemical profile of TNF-α, IL-1β, TGF-β1 and ICAM-1,"Folia Morphologica, vol. 82, no. 1, pp. 119–126, 2023.
P. Tsioufis, P. Theofilis, K. Tsioufis, and D. Tousoulis, "The Impact of Cytokines in Coronary Atherosclerotic Plaque: Current Therapeutic Approaches,"International Journal of Molecular Sciences, vol. 23, no. 24, pp. 15937, 2022.
H. Zhang and N. S. Dhalla, "The Role of Pro-Inflammatory Cytokines in the Pathogenesis of Cardiovascular Disease,"International Journal of Molecular Sciences, vol. 25, no. 2, pp. 1082, 2024.
D. Potashnikova, E. Maryukhnich, D. Vorobyeva, G. Rusakovich, A. Komissarov, A. Tvorogova, and V. Gontarenko, "Cytokine Profiling of Plasma and Atherosclerotic Plaques in Patients Undergoing Carotid Endarterectomy,"International Journal of Molecular Sciences, vol. 25, no. 2, pp. 1030, 2024.
S. Wassaifi, B. Kaeffer, and S. Zarrouk, "Cellular Phenotypic Transformation During Atherosclerosis: The Potential Role of miRNAs as Biomarkers,"International Journal of Molecular Sciences, vol. 26, no. 5, pp. 2083, 2025.
R. Zhang, W. Wang, J. Li, R. Li. "The Role of miR-155 in Cardiovascular Diseases: Potential Diagnostic and Therapeutic Targets,"International Journal of Cardiology Cardiovascular Risk and Prevention, vol. 24, 200355, 2025.
S. S. Zhou, J. P. Jin, J. Q. Wang, Z. G. Zhang, J. H. Freedman, and Y. Zheng, "miRNAs in Cardiovascular Diseases: Potential Biomarkers, Therapeutic Targets and Challenges,"Acta Pharmacologica Sinica, vol. 39, no. 7, pp. 1073–1084, July 2018.
M. Guruswamy and B. Roopa, "MicroRNA-155: A Master Regulator of Inflammation,"Journal of Interferon Cytokine Research, vol. 39, no. 6, pp. 321–330, 2019.
F.B. Abdumalikova A Model for the Multifactorial Assessment of the Risk Index for the Progression of Coronary Heart Disease. American Journal of Medicine and Medical Sciences 2024; 14(8): 2099-2103.
F.B. Abdumalikova, Nurillaeva N.M. Prognostic value of clinical, laboratory and cardio – imaging markers of progression of coronary artery disease. Central Asian Journal of Medicine. 2024;1:137-146.
R.B. Alieva, B.G. Kurbanova et al. Relationship of blood lipid spectrum indicators with coronary calcinosis due to statin treatment in patients with high cardiovascular risk Atherosclerosis, 2024-08, Vol.395, p.117720.
Abdummalikova F.B., Nurillaeva N.M. Prognostic value of psycho-emotional status in patients with ischemic heart disease in relation to disorders of the platelet component of the hemostasis system. Cardiovascular Therapy and Prevention. 2020;19(2):5–11. In Russian: Ф.Б. Абдумаликова, Н.М. Нурил- лаева. Прогностическое значение психоэмоционального статуса у больных ишемической болезнью сердца в отношении нарушений тромбоцитарного звена системы гемостаза. Кардиоваскулярная терапия и профилактика 2020; 19 (2): 5-11.
B Kurbanova, F Abdumalikova, S Jurayeva. Yuqori texnologik noinvaziv kardiovizualizatsiya usullarini yurak ishemik kasalligi avj olishini erta tashxislash va prognozlashdagi orni. O‘zbekiston kardiologiyasi. 2025; 2 (1), 71-78.
Copyright (c) 2025 Ф.Б. Абдумаликова , Н.М. Нуриллаева , Б.Г. Курбанова (Автор)
This work is licensed under a Creative Commons Attribution 4.0 International License.